Redeye Initiates Coverage of Devyser
2022-04-06 08:30:00
Redeye initiates coverage of Devyser, a rapidly growing Swedish diagnostics company that offers cutting-edge test kits in oncology, hereditary diseases, and post-transplantation monitoring. We believe the company is only at the start of its growth journey, moving even further beyond the impressive sales growth of the past five years, and we see it as a compelling investment at the current valuation.
Read more and download the Research Report.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/